DaVita Inc. (DVA) Price Target Analysis
Updated Jul 2, 2026
Analyst Rating: Hold
Based on 23 analysts13.7% Above Target
DVA trades 13.7% above Wall Street's consensus target of $202.25.
Current Price$234.31
Average Target$202.25
Target
Current
Low$190.00
Median$199.50
High$220.00
Analyst Target Range
Forward P/E15.8x
(Fair)
PEG Ratio1.91
(Fair)
Implied Growth+30.9%
(High Growth)
Analyst Spread14.8%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes DVA achieves its forward estimates and maintains a stable P/E multiple of 15.8x. This scenario reflects the blended consensus of 23 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
DVA Price Target Analysis
Updated July 8, 2026As of July 8, 2026, DaVita Inc. (DVA) has a Wall Street consensus price target of $202.25, based on estimates from 23 covering analysts. With the stock currently trading at $234.31, this represents a potential downside of -13.7%. The company has a market capitalization of $15.04B.
Analyst price targets range from a low of $190.00 to a high of $220.00, representing a 15% spread in expectations. The median target of $199.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 9 analysts rating the stock as a Buy or Strong Buy,13 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, DVA trades at a trailing P/E of 24.6x and forward P/E of 15.8x. The forward PEG ratio of 1.91 indicates reasonable valuation for growth. Analysts expect EPS to grow +30.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $311.66, with bear and bull scenarios of $196.35 and $410.64 respectively. Model confidence stands at 48/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+1.6%
Industry Consensus
Avg Forward P/E
21.0x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 FMSFresenius Medical Care AG & Co. KGaA | $13.3B | $24.20 | $28.00 | +15.7% | Hold | 12.0x | 20 |
 FXNCFirst National Corporation | $265M | $29.30 | $21.00 | -28.3% | Buy | 12.4x | 1 |
 UNHUnitedHealth Group Incorporated | $388.9B | $428.19 | $426.75 | -0.3% | Buy | 23.3x | 52 |
 HUMHumana Inc. | $47.4B | $394.62 | $298.50 | -24.4% | Hold | 44.6x | 44 |
 CNCCentene Corporation | $32.6B | $66.12 | $59.79 | -9.6% | Buy | 18.9x | 43 |
 USPHU.S. Physical Therapy, Inc. | $1.1B | $71.80 | $96.00 | +33.7% | Buy | 25.7x | 13 |
 AMSFAMERISAFE, Inc. | $663M | $35.45 | $44.50 | +25.5% | Buy | 16.9x | 6 |
 PNTGThe Pennant Group, Inc. | $1.4B | $39.70 | $39.00 | -1.8% | Buy | 29.3x | 7 |
 ADUSAddus HomeCare Corporation | $2.0B | $105.97 | $122.00 | +15.1% | Buy | 15.2x | 16 |
 BAXBaxter International Inc. | $11.8B | $22.86 | $20.71 | -9.4% | Hold | 11.9x | 36 |
DVA — Frequently Asked Questions
Quick answers to the most common questions about buying DVA stock.
What is the DVA stock price target for 2026?
DVA's consensus price target is $202.25, -13.7% below the current price of $234.31. The 23 analysts tracking DVA see downside risk at present valuations.
Is DVA a buy, sell, or hold?
DVA has a consensus rating of "Hold" based on 23 Wall Street analysts. The rating breakdown is mixed, with 13 Hold ratings making up the largest segment. The consensus 12-month price target of $202.25 implies -13.7% downside from current levels.
Is DVA stock overvalued or undervalued?
With a forward P/E of 15.782x, DVA trades at a relatively low valuation. The consensus target of $202.25 implies -13.7% move, suggesting the market may be pricing in risks.
How high can DVA stock go?
The most bullish Wall Street analyst has a price target of $220 for DVA, while the most conservative target is $190. The consensus of $202.25 represents the median expectation. Our quantitative valuation model projects a bull case target of $411 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover DVA stock?
DVA is well covered by analysts, with 23 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 9 have Buy ratings, 13 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the DVA stock forecast?
The 12-month DVA stock forecast based on 23 Wall Street analysts shows a consensus price target of $202.25, with estimates ranging from $190 (bear case) to $220 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $312, with bear/bull scenarios of $196/$411.
What is DVA's fair value based on fundamentals?
Our quantitative valuation model calculates DVA's fair value at $312 (base case), with a bear case of $196 and bull case of $411. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 48/100.
What is DVA's forward P/E ratio?
DVA trades at a forward P/E ratio of 15.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 24.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy DVA stock?
Analysts are cautious on DVA, with 1 Sell ratings and a price target of $202.25 (-13.7% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do DVA price targets vary so much?
DVA analyst price targets range from $190 to $220, a 15% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $202.25 consensus represents the middle ground. Our model's $196-$411 range provides an independent fundamental perspective.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare